What do systematic reviews say?

Clindamycin vs penicillin plus chloramphenicol compared to for

• Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 77 participants
  Moderate

Clindamycin vs penicillin plus chloramphenicol compared to for

Clindamycin showed no clear difference in complications compared with penicillin plus chloramphenicol compared to for (moderate certainty).

• Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
  RR 7.57 [0.98, 58.61]
  1 study · 77 participants
  Moderate

Penicillin plus chloramphenicol vs cephalothin plus kanamycin

• Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 56 participants
  Low

Penicillin plus chloramphenicol vs cephalothin plus kanamycin

• Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 56 participants
  Low

Tetracycline vs penicillin G

• Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 100 participants
  Low

Intervention not reported

The intervention probably leads to lower exacerbations Number of events (moderate certainty).

• Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults 2015 · Cochrane Headline outcomes only
  OR 0.31 [0.12, 0.52]
  10 studies · 654 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in hospitalisations Number of events (moderate certainty).

• Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults 2015 · Cochrane Headline outcomes only
  OR 0.4 [0.14, 1.11]
  7 studies · 643 participants
  Moderate

Intervention not reported

The intervention probably leads to higher emergence of resistance Number of events (moderate certainty).

• Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults 2015 · Cochrane Headline outcomes only
  OR 3.48 [1.2, 10.07]
  6 studies · 431 participants
  Moderate

Intervention not reported

• Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults 2015 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 315 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes clinical cure rates at day 8 ± 1 (very low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 1.07 [0.88, 1.31]
  1 study · 93 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes clinical cure rates at day 8 ± 1 (very low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 1.09 [0.9, 1.32]
  1 study · 97 participants
  Very low

Intervention not reported

The intervention showed no clear difference in laryngitis at 1 week (low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 1.1 [0.76, 1.59]
  1 study · 99 participants
  Low

Intervention not reported

The intervention showed no clear difference in laryngitis at 2 weeks (low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 0.81 [0.44, 1.49]
  1 study · 99 participants
  Low

Intervention not reported

The intervention showed no clear difference in patients having voice disturbance at 1 week (low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 0.87 [0.59, 1.28]
  1 study · 99 participants
  Low

Intervention not reported

The intervention showed no clear difference in patients having voice disturbance at 2 weeks (low certainty).

• Antibiotics for acute laryngitis in adults 2015 · Cochrane Headline outcomes only
  RR 0.56 [0.28, 1.14]
  1 study · 99 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The intervention showed no clear difference in incidence of severe infections (Grade III or IV) (low certainty).

• Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes only
  RR 1.55 [0.86, 2.8]
  1 study · 115 participants
  Low

Intervention not reported

The intervention showed no clear difference in adverse events Toxic deaths (low certainty).

• Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes only
  RR 1.32 [0.3, 5.69]
  1 study · 115 participants
  Low

Intervention not reported

• Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 40 participants
  Very low